Position in NVO
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,174,089
-$417,488 QoQ
Shares Held
31,948
+2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Dec 31, 2025CallValue
$5,088
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. NVO ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,631 | $3,331,961 | |
| 2 | NVS |
Novartis AG
|
21,135 | $3,228,371 | |
| 3 | LLY |
ELI LILLY & Co
|
3,475 | $3,196,200 | |
| 4 | GSK |
GSK plc
|
42,695 | $2,356,337 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,029 | $1,955,221 | |
| 6 | MRK |
Merck & Co., Inc.
|
14,018 | $1,686,225 | |
| 7 | ABBV |
AbbVie Inc.
|
6,748 | $1,467,622 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
31,948 | $1,174,089 |
All Filings in NVO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,174,089 | 31,948 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,088 | 100 | Call | Sole | 2026-02-24 | |
| 2025-12-31 | $1,591,577 | 31,281 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,628,187 | 29,342 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $2,694,540 | 39,040 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $2,732,672 | 39,353 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $3,509,185 | 40,795 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,001,297 | 42,003 | Shares | Sole | 2024-12-10 | |
| 2024-06-30 | $6,049,892 | 42,384 | Shares | Sole | 2024-12-10 | |
| 2024-03-31 | $5,506,819 | 42,888 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $4,317,692 | 41,737 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,848,489 | 42,319 | Shares | Sole | 2024-01-30 | |
| 2023-06-30 | $3,388,234 | 20,937 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $3,340,826 | 20,993 | Shares | Sole | 2023-06-16 | |
| 2022-12-31 | $2,840,380 | 20,987 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $2,120,724 | 21,286 | Shares | Sole | 2023-02-21 | |
| 2022-06-30 | $2,239,408 | 20,097 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,269,084 | 20,433 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,994,944 | 17,812 | Shares | Sole | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||